Table 1.
Baseline characteristics of the patients who completed interventions.
| HA (n = 30) | LR-PRP (n = 30) | LP-PRP (n = 30) | p | |
|---|---|---|---|---|
| Age, mean ± SD years | 63 ± 9.17 | 60.3 ± 7.65 | 58.93 ± 6.25 | 0.274 |
| <60 | 13 | 15 | 19 | |
| 60-69 | 10 | 11 | 7 | |
| >70 | 7 | 4 | 4 | |
| BMI, mean (SD) kg/m3 | 32.4 ± 4.2 | 31.27 ± 4.08 | 32.53 ± 6.25 | 0.370 |
| Normal | 0 | 2 | 4 | |
| Overweighed | 8 | 7 | 4 | |
| Obese | 11 | 15 | 11 | |
| Severe obese | 7 | 5 | 8 | |
| Morbidly obese | 4 | 1 | 3 | |
| Gender, (Female), no. (%) | %86.7 | %86.7 | %90 | 0.902 |
| Comorbidities | 0.561 | |||
| None | 22 | 20 | 24 | |
| HT + DM | 8 | 10 | 6 | |
| VAS | 8.77 ± 1.22 | 8.93 ± 0.94 | 8.83 ± 1,21 | 0.356 |
| WOMAC | 79.17 ± 13.27 | 82.23 ± 8.37 | 81.57 ± 13.74 | 0.322 |
Abbreviations: LP-PRP, leukocyte poor PRP; LR-PRP, leukocyte rich PRP; BMI, body mass index; DM, diabetes mellitus; HT, hypertension.